OGN
Organon & Co. · Healthcare · Drug Manufacturers - General
Momentum-inputs (vergelijkbare managers):
breedte van houders +11.8% ·
aandelenstroom -3.0% ·
netto nieuwe posities +5.3%
· formule
Fragmentatie van eigendom: meer houders, kleiner totaalbelang
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 110 | -5 | 127.45M | $1.69B | +9 | −15 |
| Q1 2026 | 119 | +3 | 138.29M | $828.86M | +8 | −6 |
| Q4 2025 | 116 | 0 | 159.06M | $1.14B | +2 | −1 |
| Q3 2025 | 19 | +2 | 102.90M | $1.10B | +2 | −1 |
| Q2 2025 | 15 | +2 | 101.45M | $982.02M | +3 | −1 |
| Q1 2025 | 10 | -1 | 22.51M | $334.60M | n/a | −1 |
| Q4 2024 | 11 | -3 | 17.81M | $265.62M | n/a | −3 |
| Q3 2024 | 13 | +3 | 12.85M | $245.79M | +4 | −1 |
| Q2 2024 | 10 | n/a | 11.89M | $246.22M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 35.93M | +11.3% | $383.72M | 0.0% | ▲ Add | 2 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (passief) | 30.86M | -0.9% | $329.57M | 0.0% | ▼ Trim | 2 | SEC ↗ ×15 |
| 3 | State Street Global Advisors ✦ (passief) | 9.34M | -1.9% | $99.70M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passief) | 4.82M | +9.6% | $51.44M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | Millennium Management ✦ | 4.53M | -50.2% | $48.35M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 6 | Morgan Stanley ✦ | 4.36M | n/a | $46.54M | 0.0% | n/c | 1 | SEC ↗ ×11 |
| 7 | AQR Capital Management ✦ | 4.18M | +28.3% | $43.64M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 8 | Gotham Asset Management ✦ | 3.71M | +37.2% | $39.66M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 9 | Goldman Sachs Group ✦ | 1.66M | n/a | $17.69M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 10 | Bridgewater Associates ✦ | 668.69K | +254.9% | $7.14M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 641.36K | +310.1% | $6.85M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | JPMorgan Chase ✦ | 640.69K | n/a | $6.84M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 13 | D. E. Shaw & Co. ✦ | 490.86K | Nieuw | $5.24M | 0.0% | New | 1 | SEC ↗ ×2 |
| 14 | Citadel Advisors ✦ | 416.24K | -92.4% | $4.45M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 15 | Fidelity (FMR) ✦ | 238.95K | -74.2% | $2.55M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 16 | T. Rowe Price ✦ | 207.85K | +7.1% | $2.22M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 17 | Wellington Management ✦ | 134.43K | Nieuw | $1.44M | 0.0% | New | 1 | SEC ↗ |
| 18 | Marshall Wace ✦ | 74.84K | -5.5% | $799,323 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | GAMCO Investors ✦ | 11.63K | -5.4% | $124,208 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| D. E. Shaw & Co. | $5.24M | 0.0% |
| Wellington Management | $1.44M | 0.0% |
Verlaten
| Norges Bank | $19.78M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 604 houders, 199.08M aandelen, $1.18B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.